Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Attention deficit disorder: treatment with methylphenidate]

M M Guerreiro1, M A Montenegro, R T Piva

  • 1Departamento de Neurologia da Faculdade d Ciências Médicas, Universidade Estadual de Campinas, Brasil.

Arquivos De Neuro-Psiquiatria
|March 1, 1996
PubMed
Summary

Methylphenidate treatment showed good results in 79.1% of children with attention deficit disorder. This study highlights the efficacy and safety of methylphenidate for pediatric ADHD management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inorganic Additive Improves the Survival of the Probiotic Lacticaseibacillus rhamnosus CRL1505 During Spray Drying, Rehydration, and Storage.

Current microbiology·2021
Same author

Preservation of protective capacity of hyperimmune anti-Stx2 bovine colostrum against enterohemorrhagic Escherichia coli O157:H7 pathogenicity after pasteurization and spray-drying processes.

Journal of dairy science·2021
Same author

The production of yeast cell wall using an agroindustrial waste influences the wall thickness and is implicated on the aflatoxin B<sub>1</sub> adsorption process.

Food research international (Ottawa, Ont.)·2018
Same author

Outcomes of laparoscopic management of multicompartmental pelvic organ prolapse.

Surgical endoscopy·2018
Same author

Temporal auditory processing and phonological awareness in children with benign epilepsy with centrotemporal spikes.

BioMed research international·2015
Same author

Identification of risk factors for autism spectrum disorders in tuberous sclerosis complex.

Neurology·2011

Area of Science:

  • Pediatric Neurology
  • Child Psychiatry
  • Pharmacology

Background:

  • Attention deficit disorder (ADD) is a common neurodevelopmental disorder in children.
  • Methylphenidate is a frequently prescribed stimulant medication for ADD.
  • Understanding treatment efficacy and safety profiles is crucial for clinical practice.

Purpose of the Study:

  • To evaluate the efficacy and safety of methylphenidate in children diagnosed with attention deficit disorder (ADD) based on DSM-III criteria.
  • To assess the therapeutic response and identify potential side effects associated with methylphenidate treatment.

Main Methods:

  • A cohort of 24 children diagnosed with ADD (DSM-III) received methylphenidate.
  • Dosage ranged from 5 to 10 mg daily, administered once or twice daily.

Related Experiment Videos

  • Efficacy and side effects were systematically monitored and recorded.

    • Main Results:

    • A high efficacy rate was observed, with 79.1% of patients showing good treatment response.
    • 16.6% of patients exhibited a poor response to methylphenidate.
    • Minor side effects, including headache and nausea, were reported in two children.

    Conclusions:

    • Methylphenidate demonstrates significant efficacy in treating attention deficit disorder in children.
    • The treatment is generally well-tolerated, with a low incidence of adverse effects.
    • Methylphenidate is a safe and effective therapeutic option for pediatric ADD.